Skip to main content
OLIPASS CORPORATION logo

OLIPASS CORPORATION — Investor Relations & Filings

Ticker · 244460 ISIN · KR7244460002 KO Professional, scientific and technical activities
Open in API
Filings indexed 505 across all filing types
Latest filing 2025-04-11 AGM Information
Country KR South Korea
Listing KO 244460

About OLIPASS CORPORATION

https://www.olipass.com/front/eng/index…

OLIPASS CORPORATION is a research and development company focused on creating RNA therapeutics. The company's core activities are centered on its proprietary OliPass Peptide Nucleic Acid (OPNA) platform. OPNA is a novel technology derived from Peptide Nucleic Acid (PNA) by introducing a cationic lipid moiety onto the nucleobase. This structural modification is designed to markedly improve cell permeability, a key challenge in nucleic acid-based drug delivery. The platform is optimized to induce exon skipping by specifically binding to target pre-mRNA inside the cell nucleus, enabling the discovery and development of new therapeutic candidates.

Recent filings

Filing Released Lang Actions
주주총회소집결의 (임시주주총회)
AGM Information Classification · 98% confidence The document is a formal notice regarding the convocation of an Extraordinary General Meeting (EGM) for the company 'Olipass'. It outlines the date, time, location, and the fact that the agenda items are currently pending. This type of document is a standard regulatory filing used to notify shareholders of an upcoming meeting, which falls under the category of Proxy Solicitation & Information Statement (PSI) as it relates to the formal process of calling a shareholder meeting.
2025-04-11 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement from the company 'Olipass' regarding the setting of a record date for an Extraordinary General Meeting of shareholders. It is a standard regulatory disclosure filed with the KRX (Korea Exchange) to inform shareholders of the upcoming meeting and the associated record date. Since it is a general regulatory announcement that does not fit into specific categories like dividend notices or proxy statements, it falls under the RNS category.
2025-04-11 Korean
[기재정정]정기주주총회결과 (속회)
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official filing titled '정기주주총회결과' (Results of the Annual General Meeting) for the company '올리패스'. It details the outcomes of various agenda items voted upon during the meeting, including the approval of financial statements, election of auditors, and director compensation. This falls directly under the definition of a Declaration of Voting Results (DVA), as it reports the official results of shareholder votes at a general meeting.
2025-04-10 Korean
[기재정정]감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the company 'Olipass' titled 'Audit Report Submission' (감사보고서 제출). It provides a summary of the audit opinion, key financial data, and corrections to previously reported figures. While it contains audit-related information, it is a formal regulatory disclosure of the audit results rather than the full audit report document itself. Given the structure and content, it falls under the category of Audit Report / Information (AR). FY 2024
2025-04-08 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) titled 'Audit Report Submission' (감사보고서 제출). It provides the audit opinion (which is 'qualified' due to scope limitation), key financial data, and details regarding the auditor (Samjong KPMG). While it contains financial data, it is a specific regulatory disclosure regarding the receipt and filing of the audit report, not the full annual report itself, and it is not merely an announcement of a report's availability but the disclosure of the audit results themselves. Therefore, it fits best under the 'Audit Report / Information' category. FY 2024
2025-04-07 Korean
기타시장안내 (상장폐지 관련)
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice regarding the potential delisting of 'Olipass' due to an audit opinion of 'limitation of scope'. It explicitly mentions the delisting process and the timeline for filing an objection, which aligns with the definition of a Delisting Announcement.
2025-04-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.